3.0.0 3116 2022-10-28T01:46:13Z 2022-10-28T01:46:13Z Senate S 2019-12-19 116 ssfi00 Finance Committee Senate Standing Referred to 2019-12-19T18:04:52Z Ending the Diagnostic Odyssey Act of 2019 116 4144 HR 2019-08-05 Referred to the Subcommittee on Health. Related bill CRS Advancing Access to Precision Medicine Act 116 4393 HR 2019-09-19 Referred to the Subcommittee on Health. Related bill CRS 2019-12-19 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S7211) IntroReferral 2019-12-19 Introduced in Senate IntroReferral 10000 9 Library of Congress C001035 Sen. Collins, Susan M. [R-ME] Susan Collins R ME M. N J000300 Sen. Jones, Doug [D-AL] Doug Jones D AL 2019-12-19 True M001197 Sen. McSally, Martha [R-AZ] Martha McSally R AZ 2019-12-19 True M000639 Sen. Menendez, Robert [D-NJ] Robert Menendez D NJ 2019-12-19 True S001203 Sen. Smith, Tina [D-MN] Tina Smith D MN 2020-03-05 False Health Adoption and foster care Cell biology and embryology Child health Emergency medical services and trauma care Genetics Health care costs and insurance Health care coverage and access Health care quality Health programs administration and funding Health technology, devices, supplies Hospital care Medicaid Medical tests and diagnostic methods State and local government operations Health 00 2019-12-19 Introduced in Senate 2020-02-10T22:37:03Z Ending the Diagnostic Odyssey Act of 2019

This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.

Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease.

The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

]]> Ending the Diagnostic Odyssey Act of 2019 Display Title Ending the Diagnostic Odyssey Act of 2019 Short Title(s) as Introduced Ending the Diagnostic Odyssey Act of 2019 Introduced in Senate IS Official Title as Introduced A bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes. Introduced in Senate IS Introduced in Senate 2019-12-19T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s3116is/xml/BILLS-116s3116is.xml 2019-12-19 Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S7211) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.